MSB 3.21% $1.13 mesoblast limited

Ann: Update on BLA for Graft Versus Host Disease, page-735

  1. 1,582 Posts.
    lightbulb Created with Sketch. 177
    The FDA did not comment on manufacturing issues this time, however, did not say they are completely satisfied either. Could be another ticking bomb in the next application.
    I have to say for this price it's an opportunity buy.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.